"Best Practices" for FDA Advisory Committees

The Food & Drug Administration has wrapped up an extensive review of the advisory committee process with a plan to implement "best practices" across its system of outside expert panels. The changes, which were announced as part of FDA's response to the Institute of Medicine report on drug safety, include three guidances slated for release in 2007.